Search Results
Jun 07, 2026, 21:00 ET GIGABYTE impulsa las tecnologías de monitores gaming con imágenes optimizadas por IA y protección OLED automática
hasta en un 30 % en escenas HDR con alto nivel de APL, lo que evita la sobreexposición. La tecnología AI Super Resolution, exclusiva del modelo FM275K16P 5K Mini LED, mejora aún más la nitidez de la imagen mediante un escalado inteligente, ampliando el rendimiento visual más allá de las capacidades nativas
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET GIGABYTE impulsa las tecnologías de los monitores para juegos con imágenes optimizadas mediante IA y protección automática de OLED
brillo hasta en un 30 % en escenas HDR con un APL alto, y evitando así la sobreexposición. La función "AI Super Resolution", exclusiva del modelo FM275K16P 5K Mini LED, mejora aún más la nitidez de la imagen mediante un escalado inteligente, lo que amplía el rendimiento visual más allá de las capacidades
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET GIGABYTE fait progresser les technologies des écrans gaming à l'aide de visuels optimisés par IA et d'une protection automatique de l'OLED
les scènes HDR à niveau de lumière élevé tout en évitant la surexposition. La technologie AI Super Resolution, une exclusivité du modèle Mini LED 5K FM275K16P, améliore davantage la clarté de l'image grâce à une mise à l'échelle intelligente, étendant les performances visuelles au-delà des capacités matérielles
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET 技嘉以 AI 技術提升畫質表現與 OLED 面板保護，重塑電競螢幕顯示體驗
內容與使用情境，自動調整顯示設定，減少頻繁切換模式的次數，帶來更直覺的觀看體驗。HyperNits 則透過最佳化 EOTF 曲線，在保留高光細節的同時提升 HDR 亮度表現，在高 APL HDR 場景下最高可提升 30% 亮度，同時避免畫面過曝，呈現更真實的對比與視覺層次。本次推出的 FM275K16P 搭載獨家的 AI Super Resolution，透過 AI 智慧影像處理技術進一步提升畫面清晰度與細節表現，突破原生解析度限制，帶來更銳利細膩的視覺體驗。升級版 AI OLED CARE PRO技嘉持續透過升級版 AI OLED CARE PRO
More news about: GIGABYTE
Jun 07, 2026, 21:00 ET GIGABYTE nâng tầm công nghệ màn hình chơi game với hình ảnh được tối ưu bằng AI và bảo vệ OLED tự động
độ sáng trung bình cao mà vẫn tránh được hiện tượng phơi sáng quá mức. Riêng AI Super Resolution, công nghệ độc quyền trên mẫu màn hình Mini LED 5K FM275K16P, tiếp tục nâng cao độ sắc nét của hình ảnh thông qua nâng cấp độ phân giải thông minh, mở rộng hiệu suất hình ảnh vượt qua khả năng vốn có của phần
More news about: GIGABYTE
Jun 07, 2026, 18:54 ET Bitmine Immersion Technologies 宣佈增額 A 系列永續優先股招股定價
及 SEC 相關舉措的最終頒布與實施；數碼資產價格的波動性和不可預測性；以及比特幣和以太坊的未來價值。 實際結果以及未來表現和結果可能與前瞻性陳述中所表達者存在重大差異。 前瞻性陳述受多項條件所規限，其中不少超出公司的控制範圍，包括公司於 2025 年 11 月 21 日向 SEC 提交的 10-K 表格中「風險因素」一節所載者，以及不時修訂或更新的所有其他 SEC 文件。 公司向 SEC 提交的文件副本，可於 SEC 的網站
More news about: Bitmine Immersion Technologies, Inc.
Jun 07, 2026, 18:30 ET VolitionRx Announces Pricing of $4.6 Million Public Offering
disclosed in other documents Volition files from time to time with the SEC, including Volition's Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. These statements are based on current expectations, estimates and projections about Volition's business based, in part, on assumptions made by management.
More news about: VolitionRx Limited
Jun 07, 2026, 17:30 ET Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
LA.Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. Pharmacol Rev. 2015;67(3):564–600. doi: 10.1124/pr.115.010629Muhammad T, Pastore SF, Good K, Yu WH, Vincent JB.. FASEB Bioadv. 2025;7(3):e1480. doi: 10.1096/fba.2024-00151Dacquin R, Davey RA, Laplace C, et al. J Cell Biol.
More news about: NOVO NORDISK INC.
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not
More news about: Amgen
Jun 07, 2026, 16:04 ET CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN
tvorcovSrdcom Global CerAwards bolo štúdio CeraVe, zážitkové prostredie na tvorbu obsahu postavené v priestoroch hollywoodskeho štúdia. Tvorcovia mali k dispozícii kulisy vyrobené na mieru, profesionálnych hercov a kaskadérov a mali za úlohu posunúť hranice rozprávania príbehov o starostlivosti o pleť
More news about: CeraVe
Jun 07, 2026, 11:00 ET Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
Jun 07, 2026, 10:40 ET RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/rgc-deadline-rgc-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-regencell-bioscience-holdings-limited-securities-fraud-lawsuit-302793116.htmlSOURCE
More news about: THE ROSEN LAW FIRM, P. A.
Jun 07, 2026, 02:55 ET Bitmine Immersion Technologies annuncia il prezzo dell'offerta ampliata di azioni privilegiate perpetue di Serie A
numerose condizioni, molte delle quali esulano dal controllo della Società, comprese quelle indicate nella sezione "Fattori di rischio" del modulo 10-K della Società depositato presso la SEC il 21 novembre 2025, nonché in tutti gli altri documenti depositati presso la SEC, modificati o aggiornati di volta
More news about: Bitmine Immersion Technologies, Inc.
Jun 07, 2026, 02:41 ET BitMine Immersion Technologies anuncia a fixação do preço da oferta ampliada de ações preferenciais perpétuas da Série A
estão sujeitas a inúmeras condições, muitas delas fora do controle da Empresa, incluindo as estabelecidas na seção Fatores de Risco do Formulário 10-K da Empresa, arquivado na Comissão de Valores Mobiliários dos EUA (a "SEC") em 21 de novembro de 2025, bem como a todos os demais documentos arquivados
More news about: Bitmine Immersion Technologies, Inc.
Jun 07, 2026, 02:26 ET Bitmine Immersion Technologies anuncia el precio de ampliación de la emisión de acciones preferentes perpetuas de la Serie A
condiciones, muchas de las cuales trascienden al control de la empresa, incluidas las establecidas en la sección Factores de riesgo del formulario 10-K de la empresa presentado ante la SEC el 21 de noviembre de 2025, así como en todos los demás documentos presentados ante la SEC, con sus modificaciones
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 14:46 ET Bybit EU posiluje své postavení v Evropě před přechodem na regulaci MiCAR
směrem k regulovaným platformám přizpůsobeným místním podmínkám.Evropský trh s kryptoměnami vstupuje do nové fáze, která je čím dál více charakterizována transparentností, provozní odolností a přehlednou regulací. S tím, jak odvětví dozrává, přestávají mít uživatelé zájem pouze o přístup k digitálním
More news about: Bybit
Jun 06, 2026, 14:30 ET Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking
More news about: Eli Lilly and Company
Jun 06, 2026, 14:08 ET Bitmine Immersion Technologies Công Bố Giá của Đợt Chào Bán Cổ Phiếu Ưu Đãi Vô Thời Hạn Series A Mở Rộng
điều kiện mà một số lượng lớn trong đây nằm ngoài tầm kiểm soát của Công Ty, bao gồm những điều kiện được nêu trong phần Yếu Tố Rủi Ro thuộc Biểu Mẫu 10-K của Công Ty đã nộp cho SEC vào ngày 21 tháng 11 năm 2025, cũng như tất cả các hồ sơ khác của SEC, theo nội dung sửa đổi hoặc cập nhật tùy từng thời điểm.
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 14:01 ET Bitmine Immersion Technologies kondigt prijsstelling aan van verhoogde aanbieding van eeuwigdurende preferente aandelen uit Serie A
waarvan vele buiten de controle van het bedrijf liggen, waaronder de factoren die worden beschreven in het onderdeel Risicofactoren van het Formulier 10-K van het bedrijf, dat op 21 november 2025 is ingediend bij de SEC, evenals in alle andere SEC-documenten, zoals deze van tijd tot tijd worden gewijzigd
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:55 ET Bitmine Immersion Technologies Umumkan Penetapan Harga Untuk Penawaran Saham Preferen Perpetual Seri A yang Diperbesar
tergantung pada berbagai kondisi yang sebagian besar berada di luar kendali Perusahaan, termasuk yang ditetapkan di bagian Faktor Risiko pada Formulir 10-K Perusahaan yang diajukan ke SEC pada tanggal 21 November 2025, dan semua pengajuan lain kepada SEC, sebagaimana telah diubah atau diperbarui setelah beberapa
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:53 ET Bitmine Immersion Technologies gibt die Preisgestaltung für die aufgestockte Emission von unbefristeten Vorzugsaktien der Serie A bekannt
des Unternehmens liegen, einschließlich derjenigen, die im Abschnitt „Risikofaktoren" des am 21. November 2025 bei der SEC eingereichten Formulars 10-K des Unternehmens sowie in allen anderen bei der SEC eingereichten Unterlagen, in ihrer jeweils gültigen Fassung, dargelegt sind. Kopien der bei der SEC
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:49 ET Bitmine Immersion Technologies annonce le prix de son offre élargie d'actions privilégiées perpétuelles de série A
nombreuses conditions, dont beaucoup sont hors du contrôle de la Société, y compris celles énoncées dans la section « Risk Factors » du formulaire 10-K déposé par la Société auprès de la SEC le 21 novembre 2025, ainsi que dans tous les autres documents déposés auprès de la SEC, tels que modifiés ou mis
More news about: Bitmine Immersion Technologies, Inc.
Jun 06, 2026, 13:14 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
on the class action.What is this about: On January 29, 2026, PennyMac filed a Current Report with the Securities Exchange Commission on Form 8-K announcing PennyMac's fourth quarter and full-year 2025 financial results. The report stated that PennyMac's "servicing segment pretax income was $37.3 million,
More news about: THE ROSEN LAW FIRM, P. A.
Jun 06, 2026, 13:13 ET CERAVE NA PRVNÍCH CELOSVĚTOVÝCH CERAWARDS PŘIVÍTALO VÍCE NEŽ 100 OCENĚNÝCH TVŮRCŮ OBSAHU Z 22 ZEMÍ
tvůrceSrdcem Global CerAwards bylo CeraVe Studios, zážitkové prostředí pro tvorbu obsahu vybudované v hollywoodských filmových ateliérech. Tvůrci zde měli k dispozici speciálně navržené kulisy, profesionální herce i kaskadéry a byli vyzváni, aby posunuli hranice vyprávění příběhů o péči o pleť a zároveň představili
More news about: CeraVe
Jun 06, 2026, 13:00 ET Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
Adults with Overweight or Obesity. N Engl J Med. 2025;393:1077-1087. DOI: 10.1056/NEJMoa2500969. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389:2221–2232. Sanyal AJ, Newsome PN,
More news about: NOVO NORDISK INC.